Clinical Trial Update: A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for INCB050465 in participants with autoimmune hemolytic anemia. Results were posted on 2022-09-22.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia

Drugs mentioned

• INCB050465

Snippet

Sponsor: Incyte Corporation | Conditions: Autoimmune Hemolytic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2022-09-22